References
- Iwanaga M, Kamoi K. Patient perceptions of injection pain and anxiety: a comparison of NovoFine 32-gauge tip 6 mm and Micro Fine Plus 31-gauge 5 mm needles. Diabetes Technol Ther 2009;11:81-6
- Brod M, Kongso JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
- Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
- Hofman PL, Behrensdorf Derraik JG, Pinto TE, et al. Defining the ideal injection techniques when using 5 mm needles in children and adults. Diabetes Care 2010; 33:1940-4
- Solvig J. Needle length affects insulin deposition in normal and obese diabetes patients. Diabetes 2001;50(Suppl 2):A132
- Arendt-Nielsen L, Egekvist H, Bjerring P. Pain following controlled cutaneous insertion of needles with different diameters. Somatosens Mot Res 2006;23:37-43
- Siegmund T, Blankenfeld H, Schumm-Draeger PM. Comparison of usability and patient preference for insulin pen needles produced with different production techniques: “thin-wall” needles compared to “regular-wall” needles: an open-label study. Diabetes Technol Ther 2009;11:523-8
- Molin A, Larsen C, Lawton SA. Reduced flow resistance in insulin pen needles designed with thin wall technology. Diabetes 2002;51(Suppl 1):A475
- McKay M, Compion G, Lytzen L. A comparison of insulin injection needles on patients' perceptions of pain, handling, and acceptability: a randomized, open-label, crossover study in subjects with diabetes. Diabetes Technol Ther 2009;11:195-201
- ISO 11608-2. Pen needles for medical use -- Part 2: Requirements and test methods